DNA DAMAGE RESPONSE GENE MUTATION

Clinical trials for DNA DAMAGE RESPONSE GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new DNA DAMAGE RESPONSE GENE MUTATION trials appear

Sign up with your email to follow new studies for DNA DAMAGE RESPONSE GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Prostate cancer drug trial halted early: what we learned

Disease control Terminated

This study tested the drug niraparib, given before surgery, in 11 men with high-risk prostate cancer that had not spread. The drug targets tumors with specific DNA repair defects. The trial was stopped early, so results are limited, but the goal was to see if the drug could shrin…

Matched conditions: DNA DAMAGE RESPONSE GENE MUTATION

Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

DNA DAMAGE RESPONSE GENE MUTATION

Get alerted when new DNA DAMAGE RESPONSE GENE MUTATION trials appear

Prostate cancer drug trial halted early: what we learned